GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a remarkable shift in how we approach diabetes mellitus . These new drugs function to imitating the body’s own GLP-1 process, which https://adsbookmark.com/story21809752/glp-1-a-significant-advance-in-diabetes-treatment